But cavities can be filled, gum disease can be treated, and with the right preventive care, further damage can be stopped
Proactive compliance reviews of promotional materials may help reduce regulatory risk as FDA continues to monitor this evolving market. Rebecca Zadaka, Associate Attorney, Gardner Law How Gardner Law Can Help FDAs recent warning letters underscore the regulatory risk associated with compounded GLP-1 marketing, particularly where promotional claims overstate product status, safety, effectiveness, or comparability to approved drugs
The dual-receptor mechanism of tirzepatide and its different pharmacokinetic profile may produce different effects on central reward pathways
Microdosing GLPs involves taking a dose smaller than the traditional starting dose
Weeks 916: Active Weight-Loss Phase As doses increase into the mid-range, many people report strong appetite suppression and more predictable eating habits
If you're keeping food down, hitting your protein target, and adjusting to the appetite changes you're winning
